NeuroSense Therapeutics Ltd. (NRSN) Net income 2021–2025
NeuroSense Therapeutics Ltd. (NRSN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$11.1MFY2025 · since FY2021: -$3.2M → -$11.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.1M | -9.0% |
| FY2024 | -$10.2M | -1.0% |
| FY2023 | -$10.1M | +3.7% |
| FY2022 | -$10.5M | -225.8% |
| FY2021 | -$3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NRSN financial trends
NRSN RevenueNRSN Net marginNRSN Gross profitNRSN Gross marginNRSN Operating incomeNRSN Operating marginNRSN Operating cash flowNRSN Free cash flowNRSN Capital expendituresNRSN Return on equityNRSN Stock buybacksNRSN Dividends paidNRSN Total assetsNRSN Total liabilitiesNRSN Shareholders’ equityNRSN overview →